Gene · 1109
Papers1,988
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 1,988
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Monounsaturated and Diunsaturated Fatty Acids Sensitize Cervical Cancer to Radiation Therapy. | Cancer Res | 2022 | 36214635 | PubTator, text mining | PubMed |
| Effects of genotype and food on naltrexone exposure in adolescents. | Clin Transl Sci | 2022 | 36200172 | PubTator, text mining | PubMed |
| Identification of distinct functional thymic programming of fetal and pediatric human γδ thymocytes via single-cell analysis. | Nat Commun | 2022 | 36195611 | PubTator, text mining | PubMed |
| Immunogenicity profiling and distinct immune response in liver transplant recipients vaccinated with SARS-CoV-2 inactivated vaccines. | Front Immunol | 2022 | 36189318 | PubTator, text mining | PubMed |
| Structure and Enzymatic Activity of an Intellectual Disability-Associated Ornithine Decarboxylase Variant, G84R. | ACS Omega | 2022 | 36188294 | PubTator, text mining | PubMed |
| Work-life balance practices and organizational cynicism: The mediating role of person-job fit. | Front Psychol | 2022 | 36186307 | PubTator, text mining | PubMed |
| Pathological variants in genes associated with disorders of sex development and central causes of hypogonadism in a whole-genome reference panel of 8380 Japanese individuals. | Hum Genome Var | 2022 | 36171209 | PubTator, text mining | PubMed |
| Constructing internal audit quality evaluation index: evidence from listed companies in Jiangsu province, China. | Heliyon | 2022 | 36164523 | PubTator, text mining | PubMed |
| Overexpression of SRD5A3 in Hepatocellular Carcinoma and Its Molecular Mechanism: A Study of Bioinformatics Exploration Analysis with Experimental Verification. | Evid Based Complement Alternat Med | 2022 | 36159555 | PubTator, text mining | PubMed |
| Characterization of RARRES1 Expression on Circulating Tumor Cells as Unfavorable Prognostic Marker in Resected Pancreatic Ductal Adenocarcinoma Patients. | Cancers (Basel) | 2022 | 36139565 | PubTator, text mining | PubMed |
| Multiple Nf1 Schwann cell populations reprogram the plexiform neurofibroma tumor microenvironment. | JCI Insight | 2022 | 36134665 | PubTator, text mining | PubMed |
| Single-cell and WGCNA uncover a prognostic model and potential oncogenes in colorectal cancer. | Biol Proced Online | 2022 | 36117173 | PubTator, text mining | PubMed |
| Intra Q-body: an antibody-based fluorogenic probe for intracellular proteins that allows live cell imaging and sorting. | Chem Sci | 2022 | 36091915 | PubTator, text mining | PubMed |
| Predictors of rapid progression of estimated glomerular filtration rate among persons living with diabetes and/or hypertension in Ghana: Findings from a multicentre study. | J Clin Hypertens (Greenwich) | 2022 | 36067082 | PubTator, text mining | PubMed |
| Epidemiology of distal radius fractures: a detailed survey on a large sample of patients in a suburban area. | J Orthop Traumatol | 2022 | 36040542 | PubTator, text mining | PubMed |
| Comprehensive Analysis of Transcriptional Expression of hsa-mir-21 Predicted Target Genes and Immune Characteristics in Kidney Renal Clear Cell Carcinoma. | Int J Med Sci | 2022 | 36035369 | PubTator, text mining | PubMed |
| Ultrasensitive Detection of GRP78 in Exosomes and Observation of Migration and Proliferation of Cancer Cells by Application of GRP78-Containing Exosomes. | Cancers (Basel) | 2022 | 36010879 | PubTator, text mining | PubMed |
| A Paradoxical Role for Regulatory T Cells in the Tumor Microenvironment of Pancreatic Cancer. | Cancers (Basel) | 2022 | 36010856 | PubTator, text mining | PubMed |
| Does Childhood Obesity Trigger Neuroinflammation? | Biomedicines | 2022 | 36009499 | PubTator, text mining | PubMed |
| Classical epithelial-mesenchymal transition (EMT) and alternative cell death process-driven blebbishield metastatic-witch (BMW) pathways to cancer metastasis. | Signal Transduct Target Ther | 2022 | 35999218 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1109/papers?page=14